Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has been used in the treatment of diabetes for decades. Devices have evolved with technological advancements; some insulin pumps now feature Bluetooth connectivity and complementary smartphone applications while the use of AI technology is slowly being integrated. Modern insulin pumps are both more patient and physician-friendly as they allow for precise insulin control in diabetic patients. As a result, the number of pump users has increased manifold now totaling an estimated 350,000 patients within the United States.
With increasing smartphone and digital device usage, there is a growing opportunity for technological tools to be incorporated into diabetes self-management (DSME). Although studies are limited thus far, scientific advancements in diabetes care have reduced long-term complications by improving glucose control, and simplifying disease management. Poor glucose control can lead to long-term diabetes, micro- and macro-vascular complications, and other health issues: all of which generate higher morbidity and mortality rates. The CDC reports that 100 million U.S. adults live with diabetes or prediabetes: a number expected to rise to 592 million by 2035.